Correlation Between DongKook Pharmaceutical and Medy Tox

Can any of the company-specific risk be diversified away by investing in both DongKook Pharmaceutical and Medy Tox at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DongKook Pharmaceutical and Medy Tox into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DongKook Pharmaceutical Co and Medy Tox, you can compare the effects of market volatilities on DongKook Pharmaceutical and Medy Tox and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DongKook Pharmaceutical with a short position of Medy Tox. Check out your portfolio center. Please also check ongoing floating volatility patterns of DongKook Pharmaceutical and Medy Tox.

Diversification Opportunities for DongKook Pharmaceutical and Medy Tox

0.47

Correlation Coefficient

DongKook Pharmaceutical  Medy Tox

Very weak diversification

The 3 months correlation between DongKook and Medy is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding DongKook Pharmaceutical Co and Medy Tox in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medy Tox and DongKook Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DongKook Pharmaceutical Co are associated (or correlated) with Medy Tox. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medy Tox has no effect on the direction of DongKook Pharmaceutical i.e., DongKook Pharmaceutical and Medy Tox go up and down completely randomly.

Pair Corralation between DongKook Pharmaceutical and Medy Tox

Assuming the 90 days trading horizon DongKook Pharmaceutical Co is expected to under-perform the Medy Tox. But the stock apears to be less risky and, when comparing its historical volatility, DongKook Pharmaceutical Co is 2.73 times less risky than Medy Tox. The stock trades about -0.17 of its potential returns per unit of risk. The Medy Tox is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  12,910,000  in Medy Tox on September 25, 2024 and sell it today you would lose (350,000) from holding Medy Tox or give up 2.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

DongKook Pharmaceutical Co  vs.  Medy Tox

DongKook Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days DongKook Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, DongKook Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Medy Tox

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medy Tox has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with DongKook Pharmaceutical and Medy Tox

The main advantage of trading using opposite DongKook Pharmaceutical and Medy Tox positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DongKook Pharmaceutical position performs unexpectedly, Medy Tox can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medy Tox will offset losses from the drop in Medy Tox's long position.

The idea behind DongKook Pharmaceutical Co and Medy Tox pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.